Dr Jack Leslie Erik Ramon Gil Kathryn Gilroy Dr Saimir Luli Maja Laszczewska et al. | CXCR2 inhibition enables NASH-HCC immunotherapy | 2022 |
|
Kathryn Gilroy Professor Caroline Austin
| The Impact of the C-Terminal Domain on the Interaction of Human DNA Topoisomerase II alpha and beta with DNA | 2011 |
|
Dr Emma Meczes Kathryn Gilroy Professor Caroline Austin
| The impact of the human DNA topoisomerse II C-terminal domain on activity | 2008 |
|
Dr Miguel Lopez-Lazaro Dr Elaine Willmore Andrew Jobson Kathryn Gilroy Hannah Curtis et al. | Curcumin induces high levels of topoisomerase I- and II-DNA complexes in K562 leukemia cells | 2007 |
|
Kathryn Gilroy Chrysoula Leontiou Dr Kay Padget Professor Jeremy Lakey Professor Caroline Austin et al. | mAMSA resistant human topoisomerase IIβ mutation G465D has reduced ATP hydrolysis activity | 2006 |
|
Chrysoula Leontiou Kathryn Gilroy Gary Watters Professor Caroline Austin
| Identifying drug-resistant mutations in human topoisomerase II beta using a forced molecular evolution approach | 2004 |
|